NASDAQ · STOCK
Intuitive Surgical
$353.34
52W $328.57 – $603.88
59/100
$124.82B
39.9
1.46
Is ISRG Bullish or Bearish?
Bullish.
Innellis AI committee rates Intuitive Surgical (ISRG) Buy with a composite score of 59/100
, based on 7 analysts with 71% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +16.24 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -3.76 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Some positive signals exist — 5 consecutive earnings beats -- consistent execution — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull & Bear Case
Bull Case
- ROE of 17.8% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 39.8 is moderate-to-rich — Value
- Price-to-book of 11.3x prices in significant intangible value — Value
- Price structure making lower highs and lower lows — Technical
- MACD histogram negative -- bearish momentum — Technical
- Trend and market structure agree -- coherent bearish picture — Technical
- Bollinger bandwidth of 34.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
59/100
Agreement
71%
Analysts
7
Conviction
Moderate
Sector Rank
Top 31%
of 93 Healthcare peers
Value Analyst
neutral
54
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.8% shows genuine earnings power backing the valuation
− P/E of 39.8 is moderate-to-rich
Growth Analyst
bullish
77
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
49
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement
− Price structure making lower highs and lower lows
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 34.9% signals elevated volatility
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 57.3 to 58.8.
- New bearish signals: 4 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst, News Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12); +1 bullish signal(s).
- News Analyst: stance bullish->neutral.
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
42.3
Neutral
MACD Histogram
-0.073
Bearish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Lh Ll
Bollinger %B
0.33
Inside Bands
Price vs Moving Averages
EMA 9
$355.64
Below
EMA 21
$370.15
Below
EMA 50
$395.45
Below
EMA 200
$455.30
Below
Fundamental Analysis
Valuation
24
Growth
93
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio
39.9×
P/B Ratio
6.89×
PEG Ratio
1.88
Dividend Yield
0.00%
52W High
$603.88
52W Low
$328.57
Quality & Growth
ROE
16.0%
ROA
13.8%
Gross Margin
66.7%
Operating Margin
31.3%
Revenue Growth YoY
—
Debt / Equity
0.00
AI Fundamental Assessment
P/E ratio of 39.9 (rich relative to a 15-40x range); Price-to-book of 6.9x; PEG ratio of 1.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.3%; Gross margin of 0.7%; Current ratio of 4.96 (healthy short-term liquidity); Debt-to-equity of 0.00; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (9.09); Most recent quarter beat estimates by 9.8%; 5 consecutive earnings beats; EPS growth accelerating (-1.2% -> +12.0% QoQ); Average YoY EPS growth of 27.9%; Analyst estimates rising over recent quarters
Get the Full ISRG Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →